Wire Stories

Outsource Accelerator Calls for Outsourcing Impact Review 2024 Entries

MANILA, Philippines--(BUSINESS WIRE)--#CSR--Outsource Accelerator, the premier source of independent information, advisory, and advocacy for the outsourcing industry, is excited to…

7 months ago

Bionova Scientific, U.S. biologics CDMO of the Asahi Kasei Group, to establish a facility in Texas and launch plasmid DNA business

TOKYO & NEW YORK & DÜSSELDORF, Germany--(BUSINESS WIRE)--Asahi Kasei Medical's U.S. subsidiary Bionova Scientific, a full-service biologics CDMO, has decided…

7 months ago

AKM Achieves Successful Proof of Concept for eFuse in High Voltage 800 V Automotive Applications

Door opener for compact, fast and reliable protection of e.g., on-board chargers or DC/DC converters for electric vehicles TOKYO &…

7 months ago

Energy Vault Executes EPC and O&M Contract with ACEN Australia for 200 MW/400 MWh of Battery Energy Storage Deployments

ACEN Australia and Energy Vault to begin deployment of two battery energy storage systems (BESS), with a total capacity of…

7 months ago

Debiopharm and Genome & Company Reach Agreement for Potential First-In Class Oncology Antibody Drug Conjugate Family

Debiopharm granted exclusive global rights to use Genome & Company’s antibodies to develop potential first-in-class ADCs integrating Debiopharm’s Multilink™ technology.…

7 months ago

Inocras and Massive Bio Forge Groundbreaking Alliance to Revolutionize Cancer Care with Whole-Genome Insights and Clinical Trial Matching

SAN DIEGO--(BUSINESS WIRE)--#WGS--Inocras, a leading AI-driven whole genome testing company, and Massive Bio, a cutting-edge AI-driven clinical trial matching platform…

7 months ago

International Energy Forum Report Details EV Copper Hurdles

Generation Mining Hosting Fireside Chat with Report Co-Author TORONTO--(BUSINESS WIRE)--$genm #copper--Generation Mining Limited (TSX:GENM, OTCQB: GENMF) welcomes the recent report…

7 months ago

Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo

– Phase 2b Trial Demonstrated Statistically Significant and Clinically Meaningful Improvements Across Primary and all Secondary Endpoints up to 8…

7 months ago

Shining Bright atop Taipei 101, GIGABYTE Redefines AI Evolution Accelerated by Next-Generation Computing at COMPUTEX

TAIPEI--(BUSINESS WIRE)--#ACCEVOLUTION--Renowned globally for its research and development capabilities, GIGABYTE Technology will exhibit its products and solutions at COMPUTEX from…

7 months ago

Summit Raises $200 Million; Also Expands License Territories for Ivonescimab

$200 Million in Net Proceeds Raised at Premium to Previous Closing Price In Separate Transaction, Summit Expanded License Territories for…

7 months ago